Max Portfolio Pct.
Check
Valuation
Check
Stock Quality:
Max Portfolio Pct.
Check
Valuation
Check
IDXX Price Action
Last 7 days
7.9%
Last 30 days
10.7%
Last 90 days
11.8%
Trailing 12 Months
-0.8%
IDXX Stock Price
IDXX RSI Chart
IDXX Valuation
IDXX Price/Sales (Trailing)
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
IDXX Fundamentals
IDXX Revenue
IDXX Earnings
IDXX Profitability
IDXX Investor Care
Revenue & Growth
Revenue Breakdown
As of: Dec 31, 2024
Product
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 3.9B | 0 | 0 | 0 |
| 2024 | 3.7B | 3.8B | 3.8B | 3.9B |
| 2023 | 3.4B | 3.5B | 3.6B | 3.7B |
| 2022 | 3.3B | 3.3B | 3.3B | 3.4B |
| 2021 | 2.9B | 3.0B | 3.1B | 3.2B |
| 2020 | 2.5B | 2.5B | 2.6B | 2.7B |
| 2019 | 2.3B | 2.3B | 2.4B | 2.4B |
| 2018 | 2.0B | 2.1B | 2.2B | 2.2B |
| 2017 | 1.8B | 1.9B | 1.9B | 2.0B |
| 2016 | 1.6B | 1.7B | 1.7B | 1.8B |
| 2015 | 1.5B | 1.5B | 1.6B | 1.6B |
| 2014 | 1.4B | 1.4B | 1.5B | 1.5B |
| 2013 | 1.3B | 1.3B | 1.3B | 1.4B |
| 2012 | 1.2B | 1.3B | 1.3B | 1.3B |
| 2011 | 1.1B | 1.2B | 1.2B | 1.2B |
| 2010 | 1.1B | 1.1B | 1.1B | 1.1B |
| 2009 | 0 | 1.0B | 1.0B | 1.0B |
| 2008 | 0 | 0 | 0 | 1.0B |
Get all data in R, Python etc through our Historical Stock Data APIs
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
| CEO | Mr. Jonathan J. Mazelsky |
|---|---|
| WEBSITE | idexx.com |
| SECTOR | Healthcare |
| INDUSTRY | Diagnostics & Research |
| EMPLOYEES | 11000 |
